Mariela A. Blum

Hematology

1515 Holcombe Blvd Unit 426
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Multidisciplinary Management of Esophageal Cancer.

Multidisciplinary Management of Esophageal Cancer.

Journal: JCO oncology practice

Published: June 03, 2026

Multidisciplinary Management of Esophageal Cancer.

Multidisciplinary Management of Esophageal Cancer.

Journal: JCO oncology practice

Published: June 03, 2026

Perioperative Nivolumab and Ipilimumab with Chemotherapy and Chemoradiation for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: A Phase 1/2 Non-Randomized Clinical Trial.

Perioperative Nivolumab and Ipilimumab with Chemotherapy and Chemoradiation for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: A Phase 1/2 Non-Randomized Clinical Trial.

Journal: Cancers

Published: May 26, 2026

Immunotherapy Response in Microsatellite Instability-High Gastroesophageal Adenocarcinoma.

Immunotherapy Response in Microsatellite Instability-High Gastroesophageal Adenocarcinoma.

Journal: JAMA surgery

Published: April 15, 2026

Survival Benefit of Palliative Oophorectomy for Patients With Ovarian Metastasis From Baseline Metastatic Gastric Adenocarcinoma.

Survival Benefit of Palliative Oophorectomy for Patients With Ovarian Metastasis From Baseline Metastatic Gastric Adenocarcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 30, 2025

Evolution of Therapeutics for Locally Advanced Upper Gastrointestinal Adenocarcinoma.

Evolution of Therapeutics for Locally Advanced Upper Gastrointestinal Adenocarcinoma.

Journal: Cancers

Published: March 07, 2025

Is it time to retire preoperative radiation for localized esophageal and gastro-esophageal adenocarcinoma?

Is it time to retire preoperative radiation for localized esophageal and gastro-esophageal adenocarcinoma?

Journal: The oncologist

Published: November 08, 2024

Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy.

Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy.

Journal: Annals of surgical oncology

Published: May 28, 2024

SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel.

SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel.

Journal: Cancers

Published: February 14, 2024

Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature.

Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature.

Journal: Journal of gastrointestinal oncology

Published: January 26, 2024

Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.

Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.

Journal: International journal of cancer

Published: January 16, 2024

Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer.

Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer.

Journal: International journal of particle therapy

Published: November 07, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026